Six essential conditions for bladder-sparing strategies in bacillus Calmette-Guérin unresponsive bladder cancer

Immunotherapy. 2019 Sep;11(13):1083-1086. doi: 10.2217/imt-2019-0083. Epub 2019 Aug 6.

Shahrokh F Shariat^{1

2

3

4

5}, Dmitry V Enikeev⁵, Hadi Mostafaei^{1

6}

¹ Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, 1090, Vienna, Austria.
² Department of Urology, Weill Cornell Medical College, New York, NY 10065, USA.
³ Department of Urology, University of Texas Southwestern, Dallas, TX 75390, USA.
⁴ Department of Urology, Second Faculty of Medicine, Charles University, 15006, Prague, Czech Republic.
⁵ Institute for Urology & Reproductive Health, I.M. Sechenov First Moscow State Medical University, 119048, Moscow, Russia.
⁶ Research Center for Evidence-Based Medicine, Tabriz University of Medical Sciences, 5166, Tabriz, Iran.

No abstract available

Keywords: BCG unresponsive; bacillus Calmette-Guérin; bladder cancer; immunotherapy; non muscle invasive bladder cancer; salvage therapies.

Publication types